Receiveable Turnover: An accounting measure used to quantify a firm's effectiveness in extending credit as well as collecting debts. Calculated as: Total Revenues / Accounts Receivable
Cytosorbents Corporation (CTSO) had Receiveable Turnover of 4.86 for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
$35.59M |
|
$-20.72M |
|
$10.47M |
|
$25.13M |
|
$52.38M |
|
$-16.79M |
|
$-5.62M |
|
$-22.41M |
|
$-22.41M |
|
$-20.72M |
|
$-20.72M |
|
$-20.72M |
|
$-20.72M |
|
$-16.79M |
|
$-14.66M |
|
54.43M |
|
54.43M |
|
$-0.38 |
|
$-0.38 |
|
| Balance Sheet Financials | |
$21.60M |
|
$9.00M |
|
$25.77M |
|
$47.37M |
|
$9.82M |
|
$14.00M |
|
$26.44M |
|
$36.26M |
|
$11.11M |
|
$11.11M |
|
$11.11M |
|
54.83M |
|
| Cash Flow Statement Financials | |
$-14.43M |
|
$-0.67M |
|
$9.33M |
|
$15.62M |
|
$9.76M |
|
$-5.85M |
|
$3.76M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.20 |
|
-- |
|
-- |
|
0.56 |
|
1.26 |
|
70.59% |
|
-47.16% |
|
-47.16% |
|
-41.19% |
|
-62.96% |
|
-58.21% |
|
$-14.71M |
|
-- |
|
-- |
|
-- |
|
0.75 |
|
3.83 |
|
|
Receiveable Turnover |
4.86 |
75.06 |
|
-186.54% |
|
-186.54% |
|
-43.74% |
|
-82.53% |
|
$0.20 |
|
$-0.27 |
|
$-0.27 |
|